Verition Fund Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$793K Sell
9,300
-21,800
-70% -$1.94M 0.01% 1405
2025
Q4
$2.46M Sell
31,100
-11,500
-27% -$902K 0.01% 1421
2025
Q3
$3.41M Buy
42,600
+1,300
+3% +$111K 0.01% 1535
2025
Q2
$3.75M Buy
41,300
+15,100
+58% +$1.38M 0.02% 1404
2025
Q1
$2.45M Buy
26,200
+9,700
+59% +$869K 0.01% 1430
2024
Q4
$1.5M Sell
16,500
-21,600
-57% -$2.06M 0.01% 1754
2024
Q3
$3.96M Hold
38,100
0.02% 1007
2024
Q2
$3.7M Buy
38,100
+8,700
+30% +$803K 0.02% 903
2024
Q1
$2.65M Buy
+29,400
New +$2.49M 0.02% 1056
2022
Q4
Sell
-5,700
Closed -$400K 2224
2022
Q3
$400K Buy
+5,700
New +$447K ﹤0.01% 2042
2022
Q2
Sell
-12,500
Closed -$947K 2433
2022
Q1
$947K Buy
12,500
+7,800
+166% +$618K 0.01% 1508
2021
Q4
$401K Buy
+4,700
New +$367K ﹤0.01% 1840

Other funds holding CL

Verition Fund Management's CL Position: Q1 2026 in Review

Verition Fund Management sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 226,652 shares — an estimated $20.2M sold.

Verition Fund Management first reported a position in CL in Q2 2013 and held it in 39 quarters. The position peaked at $17.9M in Q4 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Verition Fund Management reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 226,652 Colgate-Palmolive shares in Q1 2026, an estimated $20.2M.
  • Verition Fund Management first reported a position in Colgate-Palmolive in Q2 2013 and held it in 39 quarters.
  • Verition Fund Management's Colgate-Palmolive position peaked at $17.9M in Q4 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.